Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells (Q39618964)

13 September 2017

title

Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells (English)

1 reference

13 September 2017

Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer Cells (English)

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.535056

20 November 2024

1 reference

1 reference

1 reference

Jhang Ho Pak

1 reference

13 September 2017

Won Ho Choi

1 reference

13 September 2017

Hye Mi Lee

1 reference

13 September 2017

Won-Duk Joo

1 reference

13 September 2017

Jong-Hyeok Kim

1 reference

13 September 2017

Young-Tak Kim

1 reference

13 September 2017

Yong-Man Kim

1 reference

13 September 2017

Joo-Hyun Nam

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21166495

20 November 2024

publication date

1 January 2011

1 reference

13 September 2017

January 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21166495

full work available at URL

20 November 2024

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2010.535056

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.535056

20 November 2024

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

21-28

1 reference

Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Strategies for reversing drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Increase of lipid peroxidation by cisplatin in WI38 cells but not in SV40-transformed WI38 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Peroxiredoxins, a novel protein family in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Involvement of peroxiredoxin I in protecting cells from radiation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Study of the development of chemoresistance in melanoma cell lines using proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Investigating transcriptional regulation of Prdx6 in mouse liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Regulation of 1-cys peroxiredoxin expression in the process of stromal wound healing after photorefractive keratectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Reduced expression of 1-cys peroxiredoxin in oxidative stress-induced cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Peroxiredoxin 6 delivery attenuates TNF-alpha-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2+ homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.535056

Cisplatin generates superoxide anion by interaction with DNA in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.535056

20 November 2024

Medical Science Monitor

BR22

Wozniak A

2005

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.535056

Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma

20 November 2024

1 reference

https://api.crossref.org/works/10.3109/07357907.2010.535056

20 November 2024

Identifiers

1 reference

13 September 2017

1 reference